Special report by Jason Gale on COVID-19

C-19 "it's also triggering the metabolic disease in many who didn't previously have it."

Article goes on to state older individuals found to have damaged pancreas.   “They found that COVID-19 survivors were about 39% more likely to have a new diabetes diagnosis in the six months after infection."

What is interesting in the article, "In Los Angeles, doctors report a worry pattern among children with new cases of type 2 diabetes…"

Seems this is Apabetalone country.  Children getting Type 2.  This should be an emergency for FDA.  ABL has shown to be safe and very successful in treating Type 2.

Can anyone explain why Resverlogix with Apabetalone could not solve many of the medical issues resulting with infection of COVID-19.

Sent the above to IR. 

Question, how does FDA solve the problem with children acquiring Type 2.  What medication is available to treat a child with Type 2?  Seems very uncommon.

RVX door is opening, just hoping someone is on the other side.  SideBar!